<?xml version="1.0" encoding="UTF-8"?>
<AssessmentQuestionSet xmlns="http://soap.sforce.com/2006/04/metadata">
    <assessmentQuestionDeveloperNames>EculizumabPNH_Initial_AssessmentOfSeverityAndBaseLineMeasures_Q3</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>EculizumabPNH_Initial_AssessmentOfSeverityAndBaseLineMeasures_Q4</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>EculizumabPNH_Initial_AssessmentOfSeverityAndBaseLineMeasures_Q5</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>EculizumabPNH_Initial_AssessmentOfSeverityAndBaseLineMeasures_Q6</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>EculizumabPNH_Initial_AssessmentOfSeverityAndMeasures_Q1</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>EculizumabPNH_Initial_AssessmentOfSeverityAndBaseLineMeasures_Q7</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>EculizumabPNH_Initial_AssessmentOfSeverityAndBaseLineMeasures_Q8</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>EculizumabPNH_Initial_AssessmentOfSeverityAndBaseLineMeasures_Q9</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>EculizumabPNH_Initial_AssessmentOfSeverityAnd_Measures_Q10</assessmentQuestionDeveloperNames>
    <assessmentQuestionDeveloperNames>EculizumabPNH_Initial_AssessmentOfSeverityAndMeasures_Q2</assessmentQuestionDeveloperNames>
    <developerName>EculizumabPNH_Initial_AssessmentOfSeverityAndBaseLineMeasures_QS</developerName>
    <name>EculizumabPNH_Initial_AssessmentOfSeverityAndBaseLineMeasures_QS</name>
</AssessmentQuestionSet>
